Stay updated on Empagliflozin US Comparative Effectiveness Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin US Comparative Effectiveness Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding status notice (previously Revision: v3.4.1). These are minor site maintenance changes and do not affect the study details or user actions.
    Difference
    0.5%
    Check dated 2026-02-11T02:10:36.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding affecting NIH operations and guidance to opm.gov, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T00:28:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added UI elements and metadata fields: a Show glossary option; Last Update Submitted that Met QC Criteria and Last Update Posted; a site Revision indicator (Revision: v3.4.0) and No FEAR Act Data. Removed older items: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-27T22:54:00.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Date-related metadata such as 'Last Update Posted (Estimated)' entries were added and older timestamps removed, reflecting routine record updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-20T21:44:25.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page; this metadata change does not alter study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T17:43:04.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Massachusetts is now listed under Locations with Revision: v3.3.3, and the previous Massachusetts Locations entry and the HHS Vulnerability Disclosure link have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:26:06.000Z thumbnail image

Stay in the know with updates to Empagliflozin US Comparative Effectiveness Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.